Results after simultaneous surgery and RFA liver ablation for patients with colorectal carcinoma and synchronous liver metastases.
暂无分享,去创建一个
J. Fütterer | S. Jenniskens | J. D. de Wilt | C. Verhoef | A. Moelker | D. Grünhagen | J. Wilt | M. V. van Amerongen | M. V. Amerongen | E. P. van der Stok | E. P. Stok
[1] M. Coolsen,et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial , 2018, BMC Cancer.
[2] C. Ball,et al. Synchronous colorectal liver metastases: a national survey of surgeon opinions on simultaneous resection and multidisciplinary cooperation. , 2018, Hepatobiliary surgery and nutrition.
[3] J. Fütterer,et al. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[4] B. Samstein,et al. Simultaneous Resection for Synchronous Colorectal Liver Metastasis: the New Standard of Care? , 2017, Journal of Gastrointestinal Surgery.
[5] M. Gonen,et al. Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. , 2016, Surgery.
[6] J. Fütterer,et al. Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[7] I. Nagtegaal,et al. Liver Resection for Metastatic Disease; A Population-Based Analysis of Trends , 2016, Digestive Surgery.
[8] M. Gonen,et al. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. , 2015, American journal of surgery.
[9] M. Koopman,et al. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases , 2015, Clinical & Experimental Metastasis.
[10] G. Spolverato,et al. Synchronous colorectal liver metastasis: A network meta‐analysis review comparing classical, combined, and liver‐first surgical strategies , 2015, Journal of surgical oncology.
[11] K. Jong,et al. Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands , 2015, International Journal of Colorectal Disease.
[12] Jianming Xu,et al. Timing of Hepatectomy for Resectable Synchronous Colorectal Liver Metastases: For Whom Simultaneous Resection Is More Suitable - A Meta-Analysis , 2014, PloS one.
[13] K. Nastos,et al. Systematic review of surgical management of synchronous colorectal liver metastases , 2014, The British journal of surgery.
[14] K. Takeda,et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. , 2013, AJR. American journal of roentgenology.
[15] Kai Liu,et al. Meta‐analysis of simultaneous versus staged resection for synchronous colorectal liver metastases , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.
[16] P. Sanjay,et al. Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasis , 2012, Surgical Endoscopy.
[17] A. Eggermont,et al. Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy , 2011, Annals of Surgical Oncology.
[18] G. Poston,et al. Ablative therapies for colorectal liver metastases: a systematic review , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[19] Masaya Sato,et al. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review , 2011, European Radiology.
[20] Ti Zhang,et al. Treatment of Colorectal Cancer with Unresectable Synchronous Liver-Only Metastases with Combined Therapeutic Modalities , 2011, Journal of Gastrointestinal Surgery.
[21] O. Dalesio,et al. A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment , 2010, BMC Cancer.
[22] R. J. Haas,et al. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases , 2010, The British journal of surgery.
[23] S. Curley,et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? , 2010, Journal of the American College of Surgeons.
[24] Yuman Fong,et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] M. Makuuchi,et al. The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.
[26] R. Adam,et al. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. , 2007, Surgical oncology clinics of North America.
[27] D. Ribero,et al. Major Liver Resections Synchronous with Colorectal Surgery , 2006, Annals of Surgical Oncology.
[28] A. Karashmalakov,et al. Treatment of colorectal cancer with synchronous bilobar liver metastases with simultaneous bowel and liver resection plus radiofrequency ablation. , 2004, Hepato-gastroenterology.
[29] B. Davidson,et al. Strategies to Increase the Resectability of Liver Metastases from Colorectal Cancer , 2003, Digestive Surgery.
[30] L H Blumgart,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.
[31] J. Weitz,et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. , 2010, The Lancet. Oncology.